Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs ZBRA✓SelectedUSD · ZBRAGSK vs ZBRA performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs ZBRA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+868.3%
ZBRA return
+8,118.5%
Excess return
-7,250.3%
Maximum drawdown
-55.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioZBRAExcessAlpha
1D-1.3%+2.4%-3.7%-1.6%
7D-3.1%-2.4%-0.7%-2.9%
30D-0.9%-14.9%+14.1%+0.9%
3M-4.2%-12.8%+8.6%-2.8%
6M-1.6%+22.9%-24.5%-4.8%
YTD+2.6%+31.6%-29.0%-1.9%
1Y+6.2%+38.4%-32.2%+1.0%
3Y+55.0%+46.6%+8.4%+43.3%
5Y+42.8%-47.3%+90.2%+46.5%
10Y+102.1%+326.1%-224.0%+55.9%
All+868.3%+8,118.5%-7,250.3%+395.2%

Cumulative growth

Daily Returns

Daily percentage return beside ZBRA.

Daily Out/Under-Performance

Portfolio return minus ZBRA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ZBRA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded ZBRA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling